Previous 10 |
CURE Pharmaceutical ( OTCQB:CURR -10.2% ) announced the acquisition of Chemistry Holdings Inc., a formulation technology company that is developing innovative delivery systems for a variety of industries, in an all-stock transaction. More news on: CURE Pharmaceutical Holding Corp., Mer...
OXNARD, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has agreed to acquire Chemistry Holdings Inc. (“Chemistry Holdings”, “CH”), a f...
DENVER, Colo., March 26, 2019- (24/7MarketNews via COMTEX) Venture Market News for March 26, 2019. Predictive Technology Group Completes Acquisition of Taueret Laboratories SALT LAKE CITY, March 26, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in th...
OXNARD, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has successfully completed a pre-IND (Investigational New Drug) review with the U.S. Food and Drug Administration (FDA). The FDA pr...
Thanks to the emergence of the marijuana investing space, new plays are being brought to the market for public capital to support. As such, some marijuana companies have turned to the medical sector as a source of inspiration to find the benefits of the cannabis plant against various disease...
CURE Pharmaceutical ( OTCQB:CURR ) has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic cannabidiol (CBD). More news on: CURE Pharmaceutical Holding Corp., He...
OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule 1 substances to incl...
OXNARD, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced Ruben Jose King-Shaw Jr. has joined its Board of Directors. King-Shaw brings significant expertise in healthcare, government and financ...
News, Short Squeeze, Breakout and More Instantly...
Cure Pharmaceutical Holding Corp Company Name:
CURR Stock Symbol:
OTCMKTS Market:
New Initiatives Showing Encouraging Results SHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended Dec...
Avenir Wellness Solutions Issues 2024 Marketing Growth Plans to Shareholders for Seratopical Revolution Skin Care Line with Support from Nicole Kidman and Facial Plastic Surgeon Dr. Michael Persky New TikTok Shop Ready for Launch to Help Grow Brand Awareness and Product Sales SHERMAN OAKS...
New Campaigns Showing Encouraging Results SHERMAN OAKS, CA / ACCESSWIRE / November 14, 2023 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the third fiscal quarter ended S...